Medical

Global Blood Plasma Fractionation Market Opportunities and Forecast 2020-2027

  • DLR469
  • 26 March, 2022
  • Medical Care
  • Pages: 120
  • Global
Global Plasma Fractionation Market, By Product Type (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other, By Applications (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Other), By End use (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes), and opportunities and forecast 2020-2027

Plasma Fractionation Market Overview

Cohn and colleagues invented plasma fractionation, the first large-scale protein purification method, nearly 60 years ago. Human serum albumin (HSA), immunoglobulin (IG), coagulation factor VIII, and protease inhibitors are currently therapeutically significant proteins. The global Plasma Fractionation market is expected to grow at a significant rate in the coming years.

The global plasma fractionation market is expected to be propelled by an increase in demand for plasma proteins, increased investment in innovation, and an increase in the occurrence of uncommon diseases around the world. The plasma fractionation industry has been investing in the research and development of new plasma protein therapies, which have resulted in innovative medicines for patients' benefit. Furthermore, increased investment in research and development leads to technological advances in efficient and cost-effective processes for fractionating proteins from plasma, boosting the plasma fractionation market.

On the negative side, increasing market penetration by recombinant factors and strict regulations and reimbursement problems are key factors limiting the growth of the global plasma fractionation market.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Product Type, Applications, End use, and Region
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered CSL Limited, Shire plc, Sanquin, Biotest AG., GRIFOLS, Baxter International Inc., Kedrion, Octapharma and China Biologic Products Holdings, Inc.


Covid-19 Impact on Plasma Fractionation Market
 
In addition, the current Plasma Fractionation Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Plasma Fractionation Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Plasma Fractionation Market Segment Overview



Based on Product Type, the Immunoglobulin segment dominates the global plasma fractionation market. This is due to the increased occurrence of autoimmune diseases such as primary humoral immunodeficiency (PIDD), multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, and Kawasaki syndrome. This aspect increases the rate of adoption of immunoglobulins, which in turn boosts the market. Moreover, according to application, neurology is another important segment in the global plasma fractionation market. An increase in the number of neurological disorders enhances the growth of the segment. 

Plasma Fractionation Market, By Product Type
  • Immunoglobulin
    • Intravenous Immunoglobulin
    • Subcutaneous Immunoglobulin
  • Coagulation Factor Concentrates
    • Factor VIII
    • Factor IX
    • Factor XIII
    • Prothrombin Complex Concentrate
    • Von Willebrand Factor
    • Fibrinogen Concentrates 
  • Albumin
  • Protease Inhibitors
  • Other
Plasma Fractionation Market, By Application
·       Neurology
·       Immunology
·       Hematology
·       Critical Care
·       Pulmonology
·       Other

Plasma Fractionation Market, By End User
·       Hospitals and Clinics
·       Clinical Research Laboratories
·       Academic Institutes

Plasma Fractionation Regional Overview

Region-Wise, North America, and Europe are two major regions for the global Plasma Fractionation market. The high occurrence of infectious diseases such as cholera, influenza, and syphilis in North America propelled the demand for the utilization of plasma fractionation. Likewise, Europe accounted for a prominent share of the market. This is because of the presence of a large old age population that is more prone to infections.  Similarly, because of the large patient population, inadequate sanitization, and low awareness of plasma fractionation products among the people in the region, Asia Pacific is considered a developing market for plasma fractionation.

Plasma Fractionation Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Plasma Fractionation Market, Key Players

·       CSL Limited
·       Shire plc
·       Sanquin
·       Biotest AG.
·       GRIFOLS
·       Baxter International Inc.
·       Kedrion
·       Octapharma and China Biologic Products Holdings, Inc.

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the Plasma Fractionation market?

A. The global plasma fractionation market is expected to be propelled by an increase in demand for plasma proteins, increased investment in innovation, and an increase in the occurrence of uncommon diseases around the world

Q2. What are the restraining factors for the Plasma Fractionation market?

A. Increasing market penetration by recombinant factors and strict regulations and reimbursement problems are key factors limiting the growth of the global plasma fractionation market

Q3. Which segment is projected to hold the largest share in the Plasma Fractionation Market?

A. The immunoglobulin segment is projected to hold the largest share in the Plasma Fractionation Market.

Q4. Which region holds the largest share in the Plasma Fractionation market?

A. North America held the largest share in the global Plasma Fractionation market

Q5. Which are the prominent players in the Plasma Fractionation Market?

A. CSL Limited, Shire plc, Sanquin, Biotest AG., GRIFOLS, Baxter International Inc., Kedrion, Octapharma and China Biologic Products Holdings, Inc. are some key players in the Plasma Fractionation Market.
Plasma Fractionation Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Plasma Fractionation Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product Type
        • 5.2.1. Immunoglobulin
          • 5.2.1.1. Intravenous Immunoglobulin
          • 5.2.1.2. Subcutaneous Immunoglobulin
        • 5.2.2. Coagulation Factor Concentrates
          • 5.2.2.1. Factor VIII
          • 5.2.2.2. Factor IX
          • 5.2.2.3. Factor XIII
          • 5.2.2.4. Prothrombin Complex Concentrate
          • 5.2.2.5. Von Willebrand Factor
          • 5.2.2.6. Fibrinogen Concentrates
        • 5.2.3. Albumin
        • 5.2.4. Protease Inhibitors
        • 5.2.5. Other
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Neurology
        • 5.3.2. Immunology
        • 5.3.3. Hematology
        • 5.3.4. Critical Care
        • 5.3.5. Pulmonology
        • 5.3.6. Other
      • 5.4. Market Analysis, Insights and Forecast – By End User
        • 5.4.1. Hospitals and Clinics
        • 5.4.2. Clinical Research Laboratories
        • 5.4.3. Academic Institutes
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Plasma Fractionation Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product Type
        • 6.2.1. Immunoglobulin
          • 6.2.1.1. Intravenous Immunoglobulin
          • 6.2.1.2. Subcutaneous Immunoglobulin
        • 6.2.2. Coagulation Factor Concentrates
          • 6.2.2.1. Factor VIII
          • 6.2.2.2. Factor IX
          • 6.2.2.3. Factor XIII
          • 6.2.2.4. Prothrombin Complex Concentrate
          • 6.2.2.5. Von Willebrand Factor
          • 6.2.2.6. Fibrinogen Concentrates
        • 6.2.3. Albumin
        • 6.2.4. Protease Inhibitors
        • 6.2.5. Other
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Neurology
        • 6.3.2. Immunology
        • 6.3.3. Hematology
        • 6.3.4. Critical Care
        • 6.3.5. Pulmonology
        • 6.3.6. Other
      • 6.4. Market Analysis, Insights and Forecast – By End User
        • 6.4.1. Hospitals and Clinics
        • 6.4.2. Clinical Research Laboratories
        • 6.4.3. Academic Institutes
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Plasma Fractionation Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product Type
        • 7.2.1. Immunoglobulin
          • 7.2.1.1. Intravenous Immunoglobulin
          • 7.2.1.2. Subcutaneous Immunoglobulin
        • 7.2.2. Coagulation Factor Concentrates
          • 7.2.2.1. Factor VIII
          • 7.2.2.2. Factor IX
          • 7.2.2.3. Factor XIII
          • 7.2.2.4. Prothrombin Complex Concentrate
          • 7.2.2.5. Von Willebrand Factor
          • 7.2.2.6. Fibrinogen Concentrates
        • 7.2.3. Albumin
        • 7.2.4. Protease Inhibitors
        • 7.2.5. Other
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Neurology
        • 7.3.2. Immunology
        • 7.3.3. Hematology
        • 7.3.4. Critical Care
        • 7.3.5. Pulmonology
        • 7.3.6. Other
      • 7.4. Market Analysis, Insights and Forecast – By End User
        • 7.4.1. Hospitals and Clinics
        • 7.4.2. Clinical Research Laboratories
        • 7.4.3. Academic Institutes
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Plasma Fractionation Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product Type
        • 8.2.1. Immunoglobulin
          • 8.2.1.1. Intravenous Immunoglobulin
          • 8.2.1.2. Subcutaneous Immunoglobulin
        • 8.2.2. Coagulation Factor Concentrates
          • 8.2.2.1. Factor VIII
          • 8.2.2.2. Factor IX
          • 8.2.2.3. Factor XIII
          • 8.2.2.4. Prothrombin Complex Concentrate
          • 8.2.2.5. Von Willebrand Factor
          • 8.2.2.6. Fibrinogen Concentrates
        • 8.2.3. Albumin
        • 8.2.4. Protease Inhibitors
        • 8.2.5. Other
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Neurology
        • 8.3.2. Immunology
        • 8.3.3. Hematology
        • 8.3.4. Critical Care
        • 8.3.5. Pulmonology
        • 8.3.6. Other
      • 8.4. Market Analysis, Insights and Forecast – By End User
        • 8.4.1. Hospitals and Clinics
        • 8.4.2. Clinical Research Laboratories
        • 8.4.3. Academic Institutes
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Plasma Fractionation Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product Type
        • 9.2.1. Immunoglobulin
          • 9.2.1.1. Intravenous Immunoglobulin
          • 9.2.1.2. Subcutaneous Immunoglobulin
        • 9.2.2. Coagulation Factor Concentrates
          • 9.2.2.1. Factor VIII
          • 9.2.2.2. Factor IX
          • 9.2.2.3. Factor XIII
          • 9.2.2.4. Prothrombin Complex Concentrate
          • 9.2.2.5. Von Willebrand Factor
          • 9.2.2.6. Fibrinogen Concentrates
        • 9.2.3. Albumin
        • 9.2.4. Protease Inhibitors
        • 9.2.5. Other
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Neurology
        • 9.3.2. Immunology
        • 9.3.3. Hematology
        • 9.3.4. Critical Care
        • 9.3.5. Pulmonology
        • 9.3.6. Other
      • 9.4. Market Analysis, Insights and Forecast – By End User
        • 9.4.1. Hospitals and Clinics
        • 9.4.2. Clinical Research Laboratories
        • 9.4.3. Academic Institutes
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. CSL Limited
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Shire plc
      • 10.6. Sanquin
      • 10.7. Biotest AG.
      • 10.8. GRIFOLS
      • 10.9. Baxter International Inc.
      • 10.10. Kedrion
      List of Figures

      Figure 1: Global Blood Plasma Fractionation Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Blood Plasma Fractionation Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Blood Plasma Fractionation Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Blood Plasma Fractionation Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Blood Plasma Fractionation Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Blood Plasma Fractionation Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Blood Plasma Fractionation Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Blood Plasma Fractionation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Blood Plasma Fractionation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Blood Plasma Fractionation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Blood Plasma Fractionation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Blood Plasma Fractionation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Blood Plasma Fractionation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934